A Study to Evaluate the Pharmacokinetics of MEDI9929 (AMG 157) in Adolescents With Mild to Moderate Asthma
Status:
Completed
Trial end date:
2016-05-17
Target enrollment:
Participant gender:
Summary
To evaluate the PK profile of a single-dose of 140 mg subcutaneous (SC) administration of
MEDI9929 (AMG 157) in adolescent subjects with mild to moderate asthma.